To Your Health
Read more
BIOTECH & PHARMA
The challenges & opportunities facing Biotech & Pharma
Pharma has been extremely successful at finding treatments and cures for some of the most wide-spread diseases to affect mankind. One consequence of this success is that the outstanding unmet need is becoming ever more niche. This means smaller patient populations which leads to two things:
The imperative to be extremely efficient in R&D.
Biotech and pharma are facing ever-increasing pressure to improve R&D productivity – essentially make better breakthroughs, faster, with less waste – so that reasonable ROI can be maintained on developing drugs for smaller patient populations. Access to data to enable this has never been so good, but still it is incredibly challenging to make good use of what data is available, often because it is not quite what you need and it needs a lot of manipulation to make it usable and valuable. All of this slows you down and takes valuable resources away from what really matters – developing insights and making breakthroughs. At Velsera we understand this. We have over a decade of working with over 18,000 researchers to make sense of complex clinical-genomic data. More recently our data harmonization capabilities are helping researchers spend less time on data preparation and more time on insights.
Requirements for companion diagnostics to confirm need for high-cost treatments.
Rarer treatments typically command higher prices to make the ROI equation work. Regulators and payors are eager to ensure money is well spent and so increasingly mandate the use of specific Companion Diagnostics (CDx) to ensure that a patient is the right fit for a treatment and they are likely to have a positive response. This CDx becomes the gate-keeper to patients getting access to novel treatments so designing it and deploying it in a way that optimizes access and uptake is key to enabling patients to quickly access care. At Velsera we have unique experience across both the R&D and clinical domains and can help you to design and deploy extremely effective diagnostics that will enable you to scale access to your new launches fast.
Why partner with Velsera
Better
Velsera’s Seven Bridges platform is a staple of bioinformatic research and provides best-in-class tools to help you see the insights amongst the data. With 950+ out of the box tools and workflows and expert support on hand to help you customize our technology to your needs, we are confident you will be in the best hands with Velsera.
Faster
Velsera’s unique position as a leader in both bioinformatics for pharma R&D as well as clinical diagnostics allows us to develop better companion diagnostics that will get faster uptake in clinical labs, accelerating diagnoses and decisions that can boost your launch success.
Simpler
Velsera understands that data is valuable, but discoveries are the end-goal. Using our data harmonization teams and tools you can spend all your time on insights and reduce the need for preparing and pre-processing data, while our expert bioinformaticians and technology teams can modify our solutions to do exactly what you need, reducing your time spent on mundane or low value-add tasks.
Solutions
Analysis & Bioinformatics
Clinical & 'omic data unlock
With Velsera’s help, diagnostic labs are uncovering opportunities embedded within the data they already collect. By harmonizing scattered, siloed, and unstructured clinical-genomic information, we are helping labs assemble data and make this available to Biotech and Pharma for novel discovery work. Learn how we can help you access new data sources to advance your research priorities.
Companion Diagnostic Development & Scaling
Technology
Services
Our experienced team of in-house bioinformaticians can help with any aspect of bioinformatics support including augmenting your internal teams to develop market leading analysis pipelines.
Our team of experts in clinical-genomic data can help you to harmonize and make use of your valuable data, through our tool-assisted ingestion approach coupled with our ARIA technology.
Our in-house Science team can help you to construct and then run your study, supporting with program co-ordination and engaging the research community to further your research efforts.
Our experienced team has many years of experience working with regulatory bodies (e.g., CLIA, FDA etc.), enabling us to develop advanced offerings to guide you through the process of achieving regulatory approval as quickly and efficiently as possible.
Our clinical experts have all the tools to help your customers to get up and running with running companion diagnostics quickly, including – clinical validation, SOP writing, Revenue Cycle Management (RCM) & re-imbursement support, mock-audits, on-site go-live support, IT integration, implementation and project management.
Real-world impact, trusted partnerships
“Interpreting large-scale, complex transcriptomics data is critically important for understanding the molecular and cellular basis of disease. We are confident that by working with the unique multi-cloud technology developed by Velsera and by benefiting from the depth and breadth of their expertise in bioinformatics and cloud computing, these solutions will assist us in maximizing the value of the data we generate.”
Blog
On January 14, 2025 | By Gareth Shercliff
Read more
Blog
On December 12, 2024 | By Jovana Babic
Read more
Blog
On October 29, 2024 | By Christopher Wilkinson
Read more
Blog
On October 10, 2024 | By Cates Mallaney
Read more
Schedule a personalized demo today to discover how our expertise can help you deliver more tailored care and improve outcomes for patients worldwide.